| Year |
Citation |
Score |
| 2014 |
Youn P, Chen Y, Furgeson DY. A myristoylated cell-penetrating peptide bearing a transferrin receptor-targeting sequence for neuro-targeted siRNA delivery. Molecular Pharmaceutics. 11: 486-95. PMID 24387132 DOI: 10.1021/Mp400446V |
0.38 |
|
| 2014 |
Chen Y, Youn P, Furgeson DY. Corrigendum to “Thermo-targeted drug delivery of geldanamycin with diblock elastin-based biopolymers” [J. Control. Release 155 (2011) 175–183] Journal of Controlled Release. 180: 91. DOI: 10.1016/J.Jconrel.2014.02.017 |
0.333 |
|
| 2012 |
Chen TH, Bae Y, Furgeson DY, Kwon GS. Biodegradable hybrid recombinant block copolymers for non-viral gene transfection. International Journal of Pharmaceutics. 427: 105-12. PMID 21983093 DOI: 10.1016/J.Ijpharm.2011.09.035 |
0.681 |
|
| 2011 |
Chen Y, Chen Y, Youn P, Youn P, Furgeson DY, Furgeson DY. Thermo-targeted drug delivery of geldanamycin to hyperthermic tumor margins with diblock elastin-based biopolymers. Journal of Controlled Release : Official Journal of the Controlled Release Society. 155: 175-83. PMID 21846483 DOI: 10.1016/J.Jconrel.2011.07.040 |
0.378 |
|
| 2008 |
Chen TH, Bae Y, Furgeson DY. Intelligent biosynthetic nanobiomaterials (IBNs) for hyperthermic gene delivery. Pharmaceutical Research. 25: 683-91. PMID 17762916 DOI: 10.1007/S11095-007-9382-5 |
0.622 |
|
| 2007 |
Bae Y, Buresh RA, Williamson TP, Chen TH, Furgeson DY. Intelligent biosynthetic nanobiomaterials for hyperthermic combination chemotherapy and thermal drug targeting of HSP90 inhibitor geldanamycin. Journal of Controlled Release : Official Journal of the Controlled Release Society. 122: 16-23. PMID 17651857 DOI: 10.1016/J.Jconrel.2007.06.005 |
0.619 |
|
| 2006 |
Liu W, Dreher MR, Furgeson DY, Peixoto KV, Yuan H, Zalutsky MR, Chilkoti A. Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice. Journal of Controlled Release : Official Journal of the Controlled Release Society. 116: 170-8. PMID 16919353 DOI: 10.1016/J.Jconrel.2006.06.026 |
0.606 |
|
| 2006 |
Furgeson DY, Dreher MR, Chilkoti A. Structural optimization of a "smart" doxorubicin-polypeptide conjugate for thermally targeted delivery to solid tumors. Journal of Controlled Release : Official Journal of the Controlled Release Society. 110: 362-9. PMID 16303202 DOI: 10.1016/J.Jconrel.2005.10.006 |
0.666 |
|
| 2005 |
Janát-Amsbury MM, Yockman JW, Lee M, Kern S, Furgeson DY, Bikram M, Kim SW. Local, non-viral IL-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment. Journal of Controlled Release : Official Journal of the Controlled Release Society. 101: 273-85. PMID 15588911 DOI: 10.1016/J.Jconrel.2004.08.015 |
0.472 |
|
| 2004 |
Furgeson DY, Yockman JW, Janat MM, Kim SW. Tumor efficacy and biodistribution of linear polyethylenimine-cholesterol/DNA complexes. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 837-45. PMID 15194050 DOI: 10.1016/J.Ymthe.2004.02.014 |
0.413 |
|
| 2004 |
Janát-Amsbury MM, Yockman JW, Lee M, Kern S, Furgeson DY, Bikram M, Kim SW. Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 829-36. PMID 15194049 DOI: 10.1016/J.Ymthe.2004.03.015 |
0.455 |
|
| 2003 |
Furgeson DY, Chan WS, Yockman JW, Kim SW. Modified linear polyethylenimine-cholesterol conjugates for DNA complexation. Bioconjugate Chemistry. 14: 840-7. PMID 12862439 DOI: 10.1021/Bc0340565 |
0.435 |
|
| 2002 |
Furgeson DY, Cohen RN, Mahato RI, Kim SW. Novel water insoluble lipoparticulates for gene delivery. Pharmaceutical Research. 19: 382-90. PMID 12033368 DOI: 10.1023/A:1015166806366 |
0.428 |
|
| 2001 |
Benns JM, Maheshwari A, Furgeson DY, Mahato RI, Kim SW. Folate-PEG-folate-graft-polyethylenimine-based gene delivery. Journal of Drug Targeting. 9: 123-39. PMID 11697107 DOI: 10.3109/10611860108997923 |
0.557 |
|
| Show low-probability matches. |
